IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MUSSONI, LUCIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.546
NA - Nord America 5.885
AS - Asia 5.709
SA - Sud America 427
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 16
Totale 19.668
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.696
GB - Regno Unito 2.805
CN - Cina 1.798
SG - Singapore 1.476
IT - Italia 1.074
DE - Germania 1.009
SE - Svezia 802
RU - Federazione Russa 580
BD - Bangladesh 493
HK - Hong Kong 412
VN - Vietnam 329
TR - Turchia 314
BR - Brasile 295
FR - Francia 290
IN - India 267
KR - Corea 234
NL - Olanda 231
UA - Ucraina 225
IE - Irlanda 167
EU - Europa 145
JP - Giappone 143
FI - Finlandia 136
CA - Canada 135
PL - Polonia 90
ID - Indonesia 62
PH - Filippine 60
CO - Colombia 55
GR - Grecia 46
BE - Belgio 25
AR - Argentina 21
MX - Messico 21
CI - Costa d'Avorio 20
IQ - Iraq 19
CL - Cile 16
EC - Ecuador 14
SA - Arabia Saudita 13
PK - Pakistan 12
AU - Australia 11
MY - Malesia 10
UZ - Uzbekistan 10
DK - Danimarca 9
ES - Italia 9
VE - Venezuela 9
CH - Svizzera 8
CZ - Repubblica Ceca 7
DZ - Algeria 7
KE - Kenya 7
AZ - Azerbaigian 6
JM - Giamaica 6
MA - Marocco 6
PY - Paraguay 6
TH - Thailandia 6
TW - Taiwan 6
ZA - Sudafrica 6
AT - Austria 5
JO - Giordania 5
NZ - Nuova Zelanda 5
RO - Romania 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
HU - Ungheria 4
IL - Israele 4
IR - Iran 4
NG - Nigeria 4
PA - Panama 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
ET - Etiopia 3
HN - Honduras 3
KZ - Kazakistan 3
PE - Perù 3
PS - Palestinian Territory 3
SV - El Salvador 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GT - Guatemala 2
HR - Croazia 2
LT - Lituania 2
ML - Mali 2
MN - Mongolia 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
CW - ???statistics.table.value.countryCode.CW??? 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
KH - Cambogia 1
Totale 19.779
Salva come PNG Salva come JPEG
Città #
Southend 2.640
Singapore 811
Ashburn 566
Chandler 404
Hong Kong 402
San Jose 368
Beijing 365
Santa Clara 320
Seattle 314
Milan 281
Wilmington 278
Princeton 253
Hanover 195
Council Bluffs 187
Dublin 165
Redmond 155
Boise 138
Ann Arbor 134
Nanjing 131
Mountain View 130
Jacksonville 126
Los Angeles 116
Dearborn 108
New York 108
Sakarya 106
Fairfield 102
Bengaluru 97
Munich 97
Dallas 94
Lauterbourg 93
Buffalo 92
Ho Chi Minh City 86
Des Moines 77
Serra 77
Moscow 74
Guangzhou 71
Boardman 70
Toronto 68
Hanoi 66
Shanghai 65
Frankfurt am Main 64
Somerville 64
Woodbridge 64
Jinan 62
Andover 56
Warsaw 55
Shenyang 51
Bogotá 48
Cambridge 48
Grafing 48
Hangzhou 46
Athens 45
Centro 45
Rome 45
Houston 43
Hebei 42
Seoul 40
Bitonto 39
Tianjin 39
Changsha 38
Nanchang 38
Berlin 36
Kansas City 35
Eitensheim 34
Zhengzhou 34
São Paulo 33
Tokyo 33
Jakarta 31
Columbus 30
The Dalles 28
Nürnberg 25
Phoenix 25
Tanggu 25
Brussels 24
Cangzhou 24
Kiez 24
Naples 24
Ottawa 24
Bühl 23
Helsinki 23
Medford 23
Hefei 22
Redwood City 21
Turin 21
Fuzhou 20
Abidjan 19
Scranton 18
Taizhou 18
Dong Ket 17
Jiaxing 17
Ningbo 17
Roxbury 17
Washington 17
San Diego 16
Chicago 15
Genoa 14
Hamburg 14
Kunming 14
Shenzhen 14
Pisa 13
Totale 11.932
Salva come PNG Salva come JPEG
Nome #
Effect of valsartan on angiotensin II-induced plasminogen activator inhibitor-1 biosynthesis in arterial smooth muscle cells 461
Pentoxifylline prevents spontaneous brain ischemia in stroke-prone rats 395
Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: effects of beta-fibrinogen genotype and environmental factors. The HIFMECH Study 361
D-dimer is associated with arterial and venous coronary artery bypass graft occlusion 338
Neurohormonal activation is associated with increased levels of plasma matrix metalloproteinase-2 in human heart failure 285
Minor components of olive oil affect the expression of pro-atherogenic molecules and cGMP-dependent PDE5 activity 281
Effect of n-3 fatty acids on carotid atherosclerosis and hemostasis in hypertriglyceridemic patients: a double blind pilot study in primary prevention 274
Increased prothrombotic state lasting as long as one month after on-pump and off-pump coronary surgery 273
Systemic inflammation after on-pump and off-pump coronary bypass surgery: a one-month follow-up 261
Cytokines present in smokers' serum interact with smoke components to enhance endothelial dysfunction 254
Effect of n-3 fatty acids on carotid atherosclerosis and haemostasis in patients with combined hyperlipoproteinemia: a double-blind pilot study in primary prevention 252
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study 252
Effect of omega-3 PUFA on carotid IMT and haemostasis in hypertriglyceridemic patients: a longitudinal pilot study in primary prevention 246
Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL 245
Association of increased fibrin turnover and defective fibrinolytic capacity with leg atherosclerosis. The PLAT Group 241
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group 238
Antithrombotic and anti-inflammatory properties of rosuvastatin in cultured human endothelial cells 234
Minor components of olive oil modulate proatherogenic adhesion molecules involved in endothelial activation 233
Gender differences in endothelial function and inflammatory markers along the occurrence of pathological events in stroke-prone rats 232
Statins prevent tissue factor induction by protease-activated receptors 1 and 2 in human umbilical vein endothelial cells in vitro 229
Isoprostanes and oxidative stress in off-pump and on-pump coronary bypass surgery 228
Distinct roles for PAR1- and PAR2-mediated vasomotor modulation in human arterial and venous conduits 225
Plasminogen activator inhibitor type-1 mRNA expression is increased by triglyceride rich lipoproteins in human hepatoma cells 221
Rosuvastatin exerts renoprotective effects in stroke-prone rats by modulating the plasminogen/plasmin system and the metalloproteases expression 220
Lipoproteine aterogene e sintesi di PAI-1 da parte di cellule endoteliali 220
Nonrheumatic calcific aortic stenosis : an overview from basic science to pharmacological prevention 219
Rosuvastatin exerts renoprotective effects in stroke-prone rats independently of changes in cholesterol levels 219
La rosuvastatina previene il danno renale spontaneo nei ratti SHRSP modulando il sistema plasminogeno/plasmina e l’espressione delle metalloproteasi 217
Proteomic analysis of plasma from patients undergoing coronary artery bypass grafting reveals a protease/antiprotease imbalance in favor of the serpin alpha1-antichymotrypsin 217
Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats 216
Mitochondrial reactive oxygen species : a common pathway for PAR1- and PAR2-mediated tissue factor induction in human endothelial cells 216
Proteomic analysis of membrane microdomains derived from both failing and non-failing human hearts 215
The ATROCAP Study: atorvastatin and the thrombogenicity of carotid atherosclerotic plaque 215
Vascular thrombogenicity induced by progressive LDL oxidation : protection by antioxidants 213
Generation and characterization of a stable rat adult brain endothelial cell line 212
Proteome of platelets in patients with coronary artery disease 212
LDL-acetilate e sintesi di PAI-1 da parte di cellule endoteliali: ruolo del recettore scavenger 212
Prostacyclin reduction results in tissue factor (TF) upregulation and predisposes cyclooxygenase-2 knockout (COX-2KO) mice to thrombosis 207
Bezafibrate lowers plasma lipids, fibrinogen and platelet aggregability in hypertriglyceridaemia 206
Additive effect of triglyceride and insulin as determinants of plasminogen activator inhibitor-1 levels in normo and hypertriglyceridemic subjects 205
Tissue factor induction by protease-activated receptor 1 requires intact caveolin-enriched membrane microdomains in human endothelial cells 203
Lipoproteine aterogene e trombosi: aspetti cellulari 203
PAR-1 and PAR-2 activation mediates tissue factor induction in endothelial cells through a redox-sensitive signaling pathway 199
Proteomic analysis of plasma from patients undergoing coronary artery bypass grafting reveals a protease/anti-protease imbalance in favor of the serpin alpha1-antichymotrypsin 198
Expression of alternatively spliced tissue factor in human endothelial cells : induction by inflammatory stimuli and modulation by heparins 195
The role of tissue factor and P-selectin in the procoagulant response that occurs in the first month after on-pump and off-pump coronary artery bypass grafting 192
Effects of native and modified low density lipoproteins on functional and biochemical aspects of cells involved in the thrombotic process 191
Transcriptional regulation of plasminogen activator inhibitor type 1 gene by insulin: insights into the signaling pathway 190
Proteome of endothelial cell-derived procoagulant microparticles 189
Rosuvastatin exerts renoprotective effects in stroke-prone rats by modulating the plasminogen/plasmin system and metalloproteases expression 186
Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon 183
Atherosclerotic plaque as a therapeutic target. The ATROCAP Study (Atorvastatin and Thrombogenicity of Carotid Atherosclerotic Plaque). 179
Triglycerides and the fibrinolytic system 177
Triglycerides and the fibrinolytic system 174
Rosuvastatin exerts renoprotective effects in stroke-prone rats modulating the plasminogen/plasmin and metalloprotease systems 168
Oxidized LDLs influence thrombotic response and cyclooxygenase 2 168
Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells 168
Protease-activated receptors 1 and 2 activation induces tissue factor through mitochondrial reactive oxygen species 165
Hypertriglyceridemia and regulation of fibrinolytic activity 164
REGULATION OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 BY ACETYL-LDL IN HUMAN UMBIUCAL VEIN ENDOTIIELIAL CELLS 164
Very low density lipoprotein-mediated signal transduction and plasminogen activator inhibitor type 1 in cultured HepG2 cells 163
Distinct roles for PAR-1 and PAR-2 mediated vasomotor modulation in human arterial and venous conduits used in coronary artery bypass surgery 163
Effect of atorvastatin on coagulation and inflammatory variables in patients with bilateral carotid stenosis. 161
Effect of omega-3 PUFA on carotid IMT and hemostasis in hypertriglyceridemic patients: a longitudinal pilot study in primary prevention 161
Proteome of endothelial cell-derived procoagulant microparticles 160
Parnaparin reduces the extent of damage in rat brain ischemia : a nuclear magnetic resonance imaging study 160
Atherogenic lipoproteins and PAI-1 synthesis by endothelial-cells 160
Inhibition of cholesterol biosynthesis as a new antithrombotic strategy 158
Effects of triglyceride rich lipoproteins on the synthesis of plasminogen activator inhibitor 1 (PAI-1) by HepG2 cells 158
Lipoproteine aterogene ed endotelio vascolare 158
Distinct roles for PAR1 and 2-mediated vasomotor modulation in human arterial and venous conduits used in coronary artery by pass surgery 158
Induzione del PAI-1 da parte di VLDL in cellule HEPG2: meccanismi di trasduzione 156
Additive effect of triglyceride and insulin as determinants of plasminogen activator inhibitor-1 levels in normo and hypertriglyceridemic subjects 155
Effetto delle VLDL sull'espressione di mRNA per il PAI-1 in cellule HepG2 154
Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery 153
Effect of atherogenic lipoproteins on PAI-1 synthesis by endothelial cells 152
Hyperlipidemias and the fibrinolytic system 151
Triglycerides and the fibrinolytic system: in vitro regulation of the synthesis of plasminogen activator type 1 by triglyceride-rich lipoproteins in HepG2 cells 151
An increased prothrombotic state lasts up to one month after on-pump and off-pump coronary surgery 151
Triglycerides as predictor of tissue activator and of tissue plasminogen activator inhibitor type 1 levels in non obese normo and hypertriglyceridemic subjects 149
Endothelial tissue factor induction by T lymphocytes in systemic sclerosis 147
Effect of triglycerides and triglyceride rich lipoproteins on fibrinolytic system 147
Protein-Kinase-C inhibitors and gemfibrozil prevent the enhancing effect of very low density lipoproteins on the biosynthesis of plasminogen activator inhibitor type 1 by HepG2 cells 145
PAR-1 and PAR-2 activation mediates tissue factor induction in endothelial cells through a redox-sensitive signaling pathway 143
Fibrinolytic variables in prediction of atherothrombotic sequelae in patients with preexisting vascular ischaemic disease : the plat study 140
Neurohormonal activation is associated with increased levels of plasma MMP-2 in human heart failure 138
PAR-1 and PAR-2 activation mediates tissue factor induction in endothelial cells through a redox-sensitive signaling pathway 137
Antithrombotic and antiinflammatory properties of rosuvastatin in cultured human endothelial cells. 137
Antithrombotic and antiinflammatory properties of rosuvastatin in culured human endothelial cells 136
Endogenous proteolytic activity in a rat model of spontaneous cerebral stroke 135
Proteomic analysis of membrane microdomains derived from both failing and non-failing human hearts 133
Increased thrombogenic potential of human monocyte-derived macrophages spontaneously transformed into foam cells 133
Fibrinolytic variables in atherosclerotic patients-comparison between patients with and without peripheral arterial-disease (PAD) 133
The effect of synthetic malaria pigment (beta-haematin) on adhesion molecule expression and interleukin-6 production by human endothelial cells 128
Tissue factor induction by protease-activated receptor-1 requires intact caveolin-enriched membrane microdomains in human endothelial cells 127
n-3 PUFA which mechanisms? 127
Tissue factor expression and apoptosis induced by oxidised low density lipoptoteins on human umbilical endothelials cells are prevented by antioxidants 126
Influence of atherogenic lipoproteins on the thrombotic potential of endothelial cells 126
Relationship between fibrinolytic and metabolic variables: a study in patients attending a lipid clinic 125
Atherogenic lipoproteins and release of plasminogen activator inhibitor-1 (PAI-1) by endothelial cells 120
Totale 19.371
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.330
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.330
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.523 132 69 96 107 96 165 112 80 106 122 208 230
2022/20231.587 285 164 127 194 148 302 41 82 131 27 66 20
2023/2024918 35 80 51 59 218 126 18 48 23 55 83 122
2024/20252.193 70 190 27 259 303 78 51 234 112 199 148 522
2025/20265.005 448 178 433 325 442 343 468 277 554 433 589 515
2026/2027204 204 0 0 0 0 0 0 0 0 0 0 0
Totale 20.727